BioCentury | Mar 21, 2011
Finance

Eyes and ears

...Japanese rights. Sirinakis and managing partner Sinclair Dunlop previously co-invested a $30 million fund for Masa Life Science Ventures...
BioCentury | Apr 14, 2008
Finance

Ebb & Flow

...geographic atrophy, a form of dry AMD. The round was led by HealthCare Ventures and MASA Life Science Ventures...
BioCentury | Feb 11, 2008
Company News

enGene board of directors update

...Inc. , Vancouver, B.C. Business: Gene/Cell therapy, Endocrine Appointed: A. Sinclair Dunlop, managing partner at Masa Life Science Ventures...
BioCentury | Jun 19, 2006
Company News

MediQuest board of directors update

...chairman; Soren Schifter, a partner at Novo A/S; and A. Sinclair Dunlop, a director at Masa Life Science Ventures WIR...
Items per page:
1 - 4 of 4
BioCentury | Mar 21, 2011
Finance

Eyes and ears

...Japanese rights. Sirinakis and managing partner Sinclair Dunlop previously co-invested a $30 million fund for Masa Life Science Ventures...
BioCentury | Apr 14, 2008
Finance

Ebb & Flow

...geographic atrophy, a form of dry AMD. The round was led by HealthCare Ventures and MASA Life Science Ventures...
BioCentury | Feb 11, 2008
Company News

enGene board of directors update

...Inc. , Vancouver, B.C. Business: Gene/Cell therapy, Endocrine Appointed: A. Sinclair Dunlop, managing partner at Masa Life Science Ventures...
BioCentury | Jun 19, 2006
Company News

MediQuest board of directors update

...chairman; Soren Schifter, a partner at Novo A/S; and A. Sinclair Dunlop, a director at Masa Life Science Ventures WIR...
Items per page:
1 - 4 of 4